165 related articles for article (PubMed ID: 27721358)
1. Expression of Drug-Resistant Factor Genes in Hepatocellular Carcinoma Patients Undergoing Chemotherapy with Platinum Complex by Arterial Infusion.
Sakurada T; Yoshikawa M; Sunaga M; Kobayashi E; Satoh N; Yokosuka O; Ueda S
Pharmaceutics; 2010 Sep; 2(3):300-312. PubMed ID: 27721358
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of multidrug resistance genes MDR1 and cMOAT in human hepatocellular carcinoma and hepatoblastoma cell lines.
Minemura M; Tanimura H; Tabor E
Int J Oncol; 1999 Sep; 15(3):559-63. PubMed ID: 10427140
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of cMOAT (MRP2/ABCC2) is associated with decreased formation of platinum-DNA adducts and decreased G2-arrest in melanoma cells resistant to cisplatin.
Liedert B; Materna V; Schadendorf D; Thomale J; Lage H
J Invest Dermatol; 2003 Jul; 121(1):172-6. PubMed ID: 12839578
[TBL] [Abstract][Full Text] [Related]
4. Delineating the contribution of secretory transporters in the efflux of etoposide using Madin-Darby canine kidney (MDCK) cells overexpressing P-glycoprotein (Pgp), multidrug resistance-associated protein (MRP1), and canalicular multispecific organic anion transporter (cMOAT).
Guo A; Marinaro W; Hu P; Sinko PJ
Drug Metab Dispos; 2002 Apr; 30(4):457-63. PubMed ID: 11901101
[TBL] [Abstract][Full Text] [Related]
5. Expression of MRP and cMOAT in childhood neuroblastomas and malignant liver tumors and its relevance to clinical behavior.
Matsunaga T; Shirasawa H; Hishiki T; Enomoto H; Kouchi K; Ohtsuka Y; Iwai J; Yoshida H; Tanabe M; Kobayashi S; Asano T; Etoh T; Nishi Y; Ohnuma N
Jpn J Cancer Res; 1998 Dec; 89(12):1276-83. PubMed ID: 10081488
[TBL] [Abstract][Full Text] [Related]
6. Canalicular multispecific organic anion transporter/multidrug resistance protein 2 mediates low-affinity transport of reduced glutathione.
Paulusma CC; van Geer MA; Evers R; Heijn M; Ottenhoff R; Borst P; Oude Elferink RP
Biochem J; 1999 Mar; 338 ( Pt 2)(Pt 2):393-401. PubMed ID: 10024515
[TBL] [Abstract][Full Text] [Related]
7. Do cMOAT (MRP2), other MRP homologues, and LRP play a role in MDR?
Borst P; Kool M; Evers R
Semin Cancer Biol; 1997 Jun; 8(3):205-13. PubMed ID: 9441949
[TBL] [Abstract][Full Text] [Related]
8. Human canalicular multispecific organic anion transporter (cMOAT) is expressed in human lung, gastric, and colorectal cancer cells.
Narasaki F; Oka M; Nakano R; Ikeda K; Fukuda M; Nakamura T; Soda H; Nakagawa M; Kuwano M; Kohno S
Biochem Biophys Res Commun; 1997 Nov; 240(3):606-11. PubMed ID: 9398612
[TBL] [Abstract][Full Text] [Related]
9. Isolation of MOAT-B, a widely expressed multidrug resistance-associated protein/canalicular multispecific organic anion transporter-related transporter.
Lee K; Belinsky MG; Bell DW; Testa JR; Kruh GD
Cancer Res; 1998 Jul; 58(13):2741-7. PubMed ID: 9661885
[TBL] [Abstract][Full Text] [Related]
10. Expression of gamma-glutamylcysteine synthetase (gamma-GCS) and multidrug resistance-associated protein (MRP), but not human canalicular multispecific organic anion transporter (cMOAT), genes correlates with exposure of human lung cancers to platinum drugs.
Oguri T; Fujiwara Y; Isobe T; Katoh O; Watanabe H; Yamakido M
Br J Cancer; 1998 Apr; 77(7):1089-96. PubMed ID: 9569044
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of multidrug resistance (mdr) and canalicular multispecific organic anion transporter (cMOAT) genes following extrahepatic biliary obstruction in rats.
Kagawa T; Watanabe N; Sato M; Nakano A; Nishizaki Y; Hosoi K; Takashimizu S; Uchiyama J; Kimura M; Matsuzaki S
Biochem Mol Biol Int; 1998 Mar; 44(3):443-52. PubMed ID: 9556204
[TBL] [Abstract][Full Text] [Related]
12. Modulation of liver canalicular transport processes by the tyrosine-kinase inhibitor genistein: implications of genistein metabolism in the rat.
Jäger W; Winter O; Halper B; Salamon A; Sartori M; Gajdzik L; Hamilton G; Theyer G; Graf J; Thalhammer T
Hepatology; 1997 Dec; 26(6):1467-76. PubMed ID: 9397986
[TBL] [Abstract][Full Text] [Related]
13. Induction of the multispecific organic anion transporter (cMoat/mrp2) gene and biliary glutathione secretion by the herbicide 2,4,5-trichlorophenoxyacetic acid in the mouse liver.
Wielandt AM; Vollrath V; Manzano M; Miranda S; Accatino L; Chianale J
Biochem J; 1999 Jul; 341 ( Pt 1)(Pt 1):105-11. PubMed ID: 10377250
[TBL] [Abstract][Full Text] [Related]
14. Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines.
Kool M; de Haas M; Scheffer GL; Scheper RJ; van Eijk MJ; Juijn JA; Baas F; Borst P
Cancer Res; 1997 Aug; 57(16):3537-47. PubMed ID: 9270026
[TBL] [Abstract][Full Text] [Related]
15. Characterization of MOAT-C and MOAT-D, new members of the MRP/cMOAT subfamily of transporter proteins.
Belinsky MG; Bain LJ; Balsara BB; Testa JR; Kruh GD
J Natl Cancer Inst; 1998 Nov; 90(22):1735-41. PubMed ID: 9827529
[TBL] [Abstract][Full Text] [Related]
16. Regulation of organic anion transport in the liver.
Roelofsen H; Müller M; Jansen PL
Yale J Biol Med; 1997; 70(4):435-45. PubMed ID: 9626764
[TBL] [Abstract][Full Text] [Related]
17. Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA.
Evers R; Kool M; van Deemter L; Janssen H; Calafat J; Oomen LC; Paulusma CC; Oude Elferink RP; Baas F; Schinkel AH; Borst P
J Clin Invest; 1998 Apr; 101(7):1310-9. PubMed ID: 9525973
[TBL] [Abstract][Full Text] [Related]
18. Effect of multidrug resistance-reversing agents on transporting activity of human canalicular multispecific organic anion transporter.
Chen ZS; Kawabe T; Ono M; Aoki S; Sumizawa T; Furukawa T; Uchiumi T; Wada M; Kuwano M; Akiyama SI
Mol Pharmacol; 1999 Dec; 56(6):1219-28. PubMed ID: 10570049
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of xenobiotic detoxification system mediated by efflux transporters].
Suzuki H
Yakugaku Zasshi; 1999 Nov; 119(11):822-34. PubMed ID: 10590710
[TBL] [Abstract][Full Text] [Related]
20. MOAT-E (ARA) is a full-length MRP/cMOAT subfamily transporter expressed in kidney and liver.
Belinsky MG; Kruh GD
Br J Cancer; 1999 Jul; 80(9):1342-9. PubMed ID: 10424734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]